@article{1bd0f8c832494aae8d641cbb791fb33c,
title = "Use of β-Blockers, Angiotensin-Converting Enzyme Inhibitors, Angiotensin II Receptor Blockers, and Risk of Breast Cancer Recurrence: A Danish Nationwide Prospective Cohort Study",
abstract = "To estimate associations between use of β-blockers, angiotensin-converting enzyme (ACE) inhibitors, or angiotensin receptor blockers (ARBs) and breast cancer recurrence in a large Danish cohort.",
keywords = "Adrenergic beta-Antagonists, Adult, Aged, Aged, 80 and over, Angiotensin Receptor Antagonists, Angiotensin-Converting Enzyme Inhibitors, Breast Neoplasms, Denmark, Female, Humans, Middle Aged, Neoplasm Recurrence, Local, Proportional Hazards Models, Prospective Studies, Registries, Risk Assessment, Risk Factors",
author = "S{\o}rensen, {Gitte Vrelits} and Ganz, {Patricia A} and Cole, {Steven W} and Pedersen, {Lars A} and S{\o}rensen, {Henrik Toft} and Deirdre Cronin-Fenton and Garne, {Jens Peter} and Christiansen, {Peer Michael} and Timothy Lash and Ahern, {Thomas P}",
year = "2013",
month = may,
day = "6",
doi = "10.1200/JCO.2012.43.9190",
language = "English",
volume = "31",
pages = "2265--72",
journal = "Journal of Clinical Oncology",
issn = "0732-183X",
publisher = "American Society of Clinical Oncology",
number = "18",
}